Bios I Pharma ApS

CVR 32672620 · Private limited company (ApS) · Active · Medium risk

Bios I Pharma ApS is a Private limited company (ApS), founded on , based in Aarhus N. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 1.4% over the next 12 months, which is 1.0 times the average for Danish companies. 14 annual reports have been published, of which 4 more than six months after the end of the financial year. The latest annual report (30 Sep 2025) shows equity of DKK 445k and a net result of DKK 206k. CEO: Henrik Beier Jessen.

Bankruptcy risk for Bios I Pharma ApS

1.4%
probability of bankruptcy within 12 months
Medium risk

1.0 × the average (1.41%) · higher risk than 75% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO's previous bankruptcies2 · bankruptcy rate 16.6%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
Moves in the last 2 years1 · bankruptcy rate 12.7%1.4×
Time at current address< 0.5 yrs · bankruptcy rate 12.0%1.4×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×
Municipality changes3+ · bankruptcy rate 10.6%1.2×
Audit opted outYes · bankruptcy rate 10.4%1.2×
Auditor registered in CVRNo · bankruptcy rate 10.4%1.2×

Reduces the risk

Reinstated after compulsory dissolutionYes · bankruptcy rate 0.0%0.00×
Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Auditor resigned in the last yearYes · bankruptcy rate 4.6%0.52×
Negative equityNo · bankruptcy rate 5.1%0.58×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
32672620
Status
Active
Company type
Private limited company (ApS)
Founded
(16 years)
Address
Palle Juul-Jensens Boulevard 82
8200 Aarhus N
Municipality
Aarhus
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Udlejning af erhvervsejendomme
Share capital
DKK 125k
Auditor
Beierholm
Audit opted out
Yes

Warning signs

Annual reports filed late4 of 14
Missing annual reportNo
Negative equityNo
Equity ratio11.6%
Current ratio114%
Moves (last 2 years)1
CEO changes in total6
CEO's previous bankruptcies2
Other companies at the address20
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -68kDKK 2.0m
Net profitDKK 206kDKK 1.7m
EquityDKK 445kDKK 239k
Total assetsDKK 3.8mDKK 3.9m
CashDKK 3,481–
Short-term debtDKK 3.3m–
Tax owedDKK 225k–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Beierholm.

Filed annual reports

Reporting periodPublishedDays after period end
1 Oct 2024 – 30 Sep 2025142
1 Oct 2023 – 30 Sep 2024233 Late
1 Oct 2022 – 30 Sep 2023195 Late
1 Oct 2021 – 30 Sep 2022111
1 Oct 2020 – 30 Sep 202187
1 Jan 2019 – 31 Dec 2019213 Late
1 Jan 2018 – 31 Dec 2018188 Late
1 Jan 2017 – 31 Dec 2017169
1 Jul 2015 – 30 Jun 2016126
1 Jul 2014 – 30 Jun 2015148
1 Jul 2013 – 30 Jun 2014154
1 Jul 2012 – 30 Jun 2013127
1 Jul 2011 – 30 Jun 2012144
15 Jan 2010 – 30 Jun 2011167

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOHenrik Beier JessenCurrent
CEOHenrik Lasse Lindblad
CEOJens Henrik Haaning
CEOHenrik Beier Jessen
Owner (100%)Beier Holding ApSCurrent
Owner (50%)FINANSMANAGEMENT ApS
Owner (50%)AQ2 A/S
AuditorBEIERHOLM, STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorBeierholm Godkendt Revisionspartnerselskab
AuditorGRANT THORNTON, STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorGrant Thornton, Godkendt Revisionspartnerselskab
AuditorBeierholm Godkendt Revisionspartnerselskab
AuditorTØNDER REVISION, GODKENDT REVISIONSAKTIESELSKAB
AuditorBeierholm Godkendt Revisionspartnerselskab
AuditorBeierholm Godkendt Revisionspartnerselskab
FounderLars AaboCurrent

The CEOs' other companies

Henrik Beier Jessen – 21 other companies, of which 2 bankrupt

Henrik Lasse Lindblad – 50 other companies, of which 8 bankrupt

Jens Henrik Haaning – 24 other companies, of which 7 bankrupt

Address history (6 moves)

Palle Juul-Jensens Boulevard 82, 8200 Aarhus N
Bobølmarkvej 8, 6683 Føvling
Særmarksvej 12, 6670 Holsted
c/o Aqagis A/S, Bautavej 1A, 8210 Aarhus V
Slotsmarken 12 th, 2970 Hørsholm
Kongevejen 153, 2830 Virum
c/o ACTIO Advokatpartnerselskab, Toldbodgade 39, 1253 København K

Former names

Bios I Pharma ApS – now
AC 01 ApS –

Other companies at the same address

Similar companies in Aarhus

Questions and answers about Bios I Pharma ApS

Has Bios I Pharma ApS gone bankrupt?

No, Bios I Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Bios I Pharma ApS?

Our model estimates a bankruptcy risk of 1.4% over the next 12 months (medium risk), which is 1.0 times the average for Danish companies.

Who is the CEO of Bios I Pharma ApS?

Henrik Beier Jessen is the CEO of Bios I Pharma ApS.

Who is the auditor of Bios I Pharma ApS?

Bios I Pharma ApS most recently used Beierholm.

When was Bios I Pharma ApS founded?

Bios I Pharma ApS was founded on 15 January 2010.

What is the equity of Bios I Pharma ApS?

Equity was DKK 445k according to the annual report for the period ending 30 September 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.